Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million

Reuters

03/12

Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million

Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2618973343"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618973343\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618973343?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 04:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618973343","market":"us","top_or_hot":-1,"title":"Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2026-03-12 04:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDLbPTyH7:1","article_id":"2618973343","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618973343","pubTimestamp":1773259369,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","KEQU":"基瓦尼科技"},"translate_title":"Kewaunee Scientific 2026财年第三季度税前收益增长26%至160万美元，国际销售额增长21%至1845万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KEQU":0.9},"content_text":"Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n    \n\n        Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}